WikiSWOT.com :: Free Wyeth SWOT Analysis

Pharmaceuticals & Biotech >> Wyeth SWOT Analysis:

Strengths Market-leading antidepressant franchise Relatively strong launch portfolio Roman est coquin	Weaknesses No follow-on product for Protonix, which loses patent protection in 2010 Over-reliance on small molecules, with little access to the high-growth biologics sector Sami est coquin
Opportunities Increase presence in the fast-growing I&I and oncology markets, through the in-licensing/acquisition of more I&I products	Threats Failure of Pristiq to recoup losses made by Effexor following its patent expiration Failure of late-stage pipeline products to reach the market

History: Version 2 (Newest), Version 1 (Oldest)

Go back to the SWOT analysis index, or start a discussion about Wyeth SWOT analysis by adding a comment below WikiSWOT Comments

Name
Email (not shared)
Website

Add comment